Imprimis Pharmaceuticals Story

Imprimis Pharmaceuticals Inc -- USA Stock  

USD 1.79  0.01  0.56%

Macroaxis does not monitor all media channels or aggregates social signals for Imprimis Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Imprimis Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Imprimis Pharmaceuticals. Please also check Imprimis Pharmaceuticals Hype Analysis, Imprimis Pharmaceuticals Correlation and Imprimis Pharmaceuticals Performance
Should You Be Concerned About Imprimis Pharmaceuticals Incs Shareholders
Simply Wall StFull coverage

Read More...   

Story Momentum

This media report from distributed on March 8, 2018 was a factor to the next trading day price decrease.The trading delta at closing time against the next closing price was 5.24% . The trading delta at closing time when the story was published against the current closing price is 16.67% .

Similar stores for Imprimis Pharmaceuticals

Did you try this?

Run Alpha Finder Now

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Hide  View All  NextLaunch Alpha Finder

Shares Owned by Insiders

Shares Owned by Insiders Comparative Analysis
  Shares Owned by Insiders 
      Imprimis Pharmaceuticals Comparables 
Imprimis Pharmaceuticals is currently under evaluation in shares owned by insiders category among related companies. Shares Owned by Insiders show percentage of outstanding shares owned by insiders (such as key officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.